Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011)
Clinical trial NCT01624974 · COMPLETED
Trial details
- NCT number
- NCT01624974
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-09
- Primary completion
- 2014-05-05
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.